E-Mail
IMAGE: Michael A. Kass, MD, (right) led the national Ocular Hypertension Treatment Study to determine whether lowering elevated eye pressure in patients might prevent vision loss from glaucoma. Kass and colleague. view more
Credit: Washington University School of Medicine
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
When the study was launched, it was universally accepted that all patients with elevated eye pressure should be given medication to lower that pressure. The Ocular Hypertension Treatment Study funded by the National Eye Institute of the National Institutes of Health (NIH) and led by researchers at Washington University School of Medicine in St. Louis recruited more than 1,600 patients nationally who were at moderate to high risk for glaucoma because of elevated eye
Why Are a Tiny Number of Vaccinated People Being Hospitalized? medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Loading video.
VIDEO: Key findings are summarized by the study s lead investigator, David G. Brauer, MD, MPHS. view more
Credit: American College of Surgeons
Key takeaways
Pancreatic, liver, bile duct, and stomach cancer operations are inherently complex and initially often take place at large cancer centers where surgical teams perform a large volume of procedures.
Readmission to a different hospital from where patients had these operations initially performed markedly increases death risk.
There are ways to address care fragmentation with newly identified risk factors for readmission; cancer hospitals should seek to determine safe sites of care for readmissions after these types of operations.
Landmark study shows most patients with elevated pressure don’t go on to lose vision
April 15, 2021 SHARE Michael A. Kass, MD, (right) led the national Ocular Hypertension Treatment Study to determine whether lowering elevated eye pressure in patients might prevent vision loss from glaucoma. Kass and colleague Mao O. Gordon, PhD, recently completed follow-up studies on patients 20 years after the start of the original study and found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma. (Photo: School of Medicine)
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
Vaccinated Nursing Moms Produce Antibodies With Potential to Protect Infants Against COVID-19: Israeli Study algemeiner.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from algemeiner.com Daily Mail and Mail on Sunday newspapers.